Foundation Medicine, Inc.

Foundation Medicine is a global, patient-focused precision medicine company that develops, manufactures, and sells comprehensive genomic profiling (CGP) assays. By leveraging next-generation sequencing (NGS) technology, the company provides diagnostic solutions for solid tumors, hematologic malignancies, and sarcomas, helping oncologists match patients with targeted therapies, immunotherapies, and clinical trials. As an independent affiliate of the Roche Group, Foundation Medicine integrates its vast genomic database with clinical data to support drug development and real-world evidence research. The company is a leader in the precision oncology space, continuously expanding its portfolio with AI-powered digital solutions and advanced monitoring tools like molecular residual disease (MRD) testing.